Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

48.43
+1.513.21%
Volume:12.18M
Turnover:585.32M
Market Cap:214.19B
PE:12.10
High:48.50
Open:47.82
Low:47.56
Close:46.92
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:1.04
T/O Rate:0.38%
Dividend:1.72
Dividend Rate:3.56%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.58
PE(LYR):13.37

Loading ...

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
1 hour ago

Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

TIPRANKS
·
3 hours ago

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Yesterday

Movement Alert|Novo-Nordisk A/S Rises 3.01% in Regular Trading, JPMorgan Raises Target Price to 275 DKK

Market Focus
·
Yesterday

Novo Nordisk Sales Growth Could Remain Flat This Year

Dow Jones
·
Yesterday

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Yesterday

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Yesterday

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

TIPRANKS
·
Yesterday

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Yesterday

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 24

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Dow Jones
·
Aug 24

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

TIPRANKS
·
Aug 24

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027

Reuters
·
Aug 20

Moderately bullish activity in Novo Nordisk with shares up 1.32%

TIPRANKS
·
Aug 20

Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

TIPRANKS
·
Aug 20

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Novo-Nordisk A/S Rises 3.02% in Regular Trading, Launches Low-Dose Oral Weight Loss Drug Clinical Trial

Market Focus
·
Aug 19

Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

TIPRANKS
·
Aug 19